The measurement of abnormal movement: methods developed for Huntington's disease.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Neurobehavioral toxicology and teratology

• Publication date

  1983-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 6230541
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The association of affective disorder with Huntington's Disease in a case series and in families

  1983cited by this paper
• Huntington's chorea. Investigation into the prevalence of this disease in the area covered by the North East Metropolitan Regional Hospital Board.

  1967cited by this paper

• Integrating Digital and Ancillary Technologies in the Modern Clinical Evaluation of Chorea

  2025cites this paper
• Experiences of young people growing up in a family with Huntington's disease: A meta‐ethnography of qualitative research

  2024cites this paper
• Inflammasome activation and assembly in Huntington's disease.

  2022cites this paper
• The use of wearable/portable digital sensors in Huntington's disease: A systematic review

  2021cites this paper
• Clinical manifestations of homozygote allele carriers in Huntington disease

  2019cites this paper
• Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations

  2018cites this paper
• Cognition sociale dans la maladie de Huntington : etude cognitive et par imagerie cérébrale morphologique et fonctionnelle

  2017cites this paper
• Huntington’s Disease

  2017cites this paper
• ESC-Derived BDNF-Overexpressing Neural Progenitors Differentially Promote Recovery in Huntington's Disease Models by Enhanced Striatal Differentiation

  2016cites this paper
• Globus pallidus degeneration and clinicopathological features of Huntington disease

  2016influential citation
• Troubles cognitifs et émotionnels dans la maladie de Huntington : Etude chez les patients symptomatiques et présymptomatiques et chez des rats transgéniques, modèles de la maladie de Huntington.

  2016cites this paper
• Huntington disease

  2015cites this paper
• Characterising Upper Limb Movements in Huntington's Disease and the Impact of Restricted Visual Cues

  2015cites this paper
• Non-Verbal and Verbal Fluency in Prodromal Huntington's Disease

  2015cites this paper
• Episodic Learning and Memory in Prodromal Huntington's Disease: The Role of Multimodal Encoding and Selective Reminding

  2015cites this paper
• Degeneration Cerebellar Dynamics in Huntington's Disease But Not Intact Ability to Learn Internal Models of Arm

  2015cites this paper
• Neurodegeneration of the human globus pallidus in Huntington’s disease

  2014influential citation
• Development and evaluation of biomarkers in Huntington’s Disease: furthering our understanding of the disease and preparing for clinical trials

  2014cites this paper
• Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review

  2014influential citation
• Determinants of functional disability in Huntington's disease: Role of cognitive and motor dysfunction

  2014cites this paper
• Huntington disease: natural history, biomarkers and prospects for therapeutics

  2014cites this paper
• Longitudinal Neuroimaging Biomarkers in Huntington's Disease

  2013cites this paper
• Huntington’s Enrichment Research Optimisation scheme AN INVESTIGATION INTO THE EFFECTS OF ENVIRONMENTAL ENRICHMENT ON CLINICAL MEASURES OF DISEASE PROGRESSION AND QUALITY OF LIFE IN PATIENTS WITH HUNTINGTON’S DISEASE

  2013cites this paper
• Huntington’s disease

  2013cites this paper
• Prefrontal executive function associated coupling relates to Huntington's disease stage.

  2013influential citation
• Age, CAG repeat length, and clinical progression in Huntington's disease

  2012cites this paper
• MRT-basierte Morphometrie zur Darstellung der Gehirnatrophie in frühen Stadien des Morbus Huntington - Vergleich einer manuellen und einer automatisierten Methode

  2012cites this paper
• Brain metabolite alterations and cognitive dysfunction in early Huntington's disease

  2012cites this paper
• Cognition in Huntington's Disease

  2012cites this paper
• Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease.

  2012cites this paper
• Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex.

  2012influential citation
• Quantitative connection between polyglutamine aggregation kinetics and neurodegenerative process in patients with Huntington’s disease

  2012cites this paper
• Synaptic Dysfunction in Huntington’s Disease

  2011cites this paper
• Factors contributing to institutionalization in patients with Huntington's disease

  2011cites this paper
• Biological markers of cognition in prodromal Huntington's disease: a review.

  2011cites this paper
• Modeling longitudinal change in motor and cognitive processing speed in presymptomatic Huntington's disease

  2011cites this paper
• Matter of life and death: the pharmacological approaches targeting apoptosis in brain diseases.

  2011cites this paper
• Huntington’s disease

  2010cites this paper
• Huntington’s disease: pathogenesis to animal models

  2010cites this paper
• Episodic memory in dementia: Characteristics of new learning that differentiate Alzheimer's, Huntington's, and Parkinson's diseases.

  2010cites this paper
• The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function.

  2009cites this paper
• of fixation and initiation of saccades Saccades in Huntington's disease: Predictive tracking and interaction between release

  2008cites this paper
• Phonemic fluency deficits in asymptomatic gene carriers for Huntington's disease.

  2008cites this paper
• Hand tapping: A simple, reproducible, objective marker of motor dysfunction in Huntington’s disease

  2008cites this paper
• Neuropsychological deficits in Huntington's disease gene carriers and correlates of early "conversion".

  2008cites this paper
• Analysis of Spontaneous Movements in Newborn Infants using a Triaxial Accelerometer (Pilot Study)

  2007cites this paper
• Huntington's disease: clinical characteristics, pathogenesis and therapies.

  2007cites this paper
• Chronic fatigue syndrome and related disorders in UK veterans of the Gulf War 1990–1991: results from a two-phase cohort study

  2007cites this paper
• Early cognitive deficits in Swedish gene carriers of Huntington's disease.

  2007cites this paper
• Huntington's Disease: Unraveling the Pathophysiological Cascade Behind a Singular Gene Defect

  2007cites this paper
• Complex movement behaviour and progression of Huntington's disease.

  2007cites this paper
• Striosomes and mood dysfunction in Huntington's disease.

  2007influential citation
• A four-year prospective study of cognitive functioning in Huntington's disease

  2006cites this paper
• Depression and Suicidal Ideation After Predictive Testing for Huntington's Disease: A Two-Year Follow-up Study

  2006cites this paper
• Assessment of simple movements reflects impairment in Huntington's disease

  2006cites this paper
• The association of CAG repeat length with clinical progression in Huntington disease

  2006cites this paper
• Unified Huntington's disease rating scale: clinical practice and a critical approach.

  2006cites this paper
• Psychiatric disorders in preclinical Huntington’s disease

  2006cites this paper
• Intact ability to learn internal models of arm dynamics in Huntington's disease but not cerebellar degeneration.

  2005cites this paper
• Dopamine D1 receptor number — a sensitive PET marker for early brain degeneration in Huntington's disease

  2005cites this paper
• Onset and rate of striatal atrophy in preclinical Huntington disease

  2004cites this paper
• Correlating Changes in QNE Scores to Quantified Changes in Hippocampal Surface Area and Volume in Huntington's Disease Patients

  2004cites this paper
• Homogenate Studies with Special Reference

  2004cites this paper
• Functional and motor response to low dose olanzapine in Huntington's disease: case report.

  2004cites this paper
• Congruent deterioration of complex and simple movements in patients with Huntington's disease.

  2004cites this paper
• Forgotten frontal lobe syndrome or "Executive Dysfunction Syndrome".

  2004cites this paper
• Objective assessment of motor slowness in Huntington's disease: Clinical correlates and 2‐year follow‐up

  2004cites this paper
• Huntington's disease: present treatments and future therapeutic modalities

  2004cites this paper
• Measurement of caudate nucleus area —A more accurate measurement for Huntington's disease?

  2004cites this paper
• Cognitive impairments in cerebellar degeneration: a comparison with Huntington's disease.

  2004cites this paper
• Functional brain changes in presymptomatic Huntington's disease

  2004cites this paper
• Functional MRI study of a serial reaction time task in Huntington's disease.

  2004cites this paper
• Assessment of complex movements reflects dysfunction in Huntington’s disease

  2003cites this paper
• Visual function in Huntington's disease patients and presymptomatic gene carriers

  2003cites this paper
• Impaired antagonist inhibition may contribute to akinesia and bradykinesia in Huntington's disease.

  2003cites this paper
• Huntington's disease.

  2003cites this paper
• Huntington’s disease

  2003cites this paper
• Effectiveness of Physiotherapy, Occupational Therapy, and Speech Pathology for People with Huntington's Disease: A Systematic Review

  2003cites this paper
• Predictors of neuropathological severity in 100 patients with Huntington's disease

  2003cites this paper
• Ideomotor limb apraxia in Huntington's disease: implications for corticostriate involvement.

  2003cites this paper
• Absence of movement disorders after surgical resection of glioma invading the right striatum.

  2002cites this paper
• EEG-NeuroBioFeedback Treatment of Patients with Brain Injury: Part 1: Typological Classification of Clinical Syndromes

  2002cites this paper
• Complex language functions and subcortical mechanisms: evidence from Huntington's disease and patients with non-thalamic subcortical lesions.

  2002influential citation
• Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals

  2002cites this paper
• Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington's disease.

  2002cites this paper
• High-dose olanzapine in Huntington's disease.

  2002cites this paper
• Olanzapine for Huntington's Disease: An Open Label Study

  2002cites this paper
• Psychomotor, Executive, and Memory Function in Preclinical Huntington's Disease

  2002cites this paper
• Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington's disease

  2001cites this paper
• Longitudinal evaluation of cognitive disorder in Huntington's disease

  2001influential citation
• Progression of symptoms in the early and middle stages of Huntington disease.

  2001cites this paper
• Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease

  2000cites this paper
• Subtle changes among presymptomatic carriers of the Huntington's disease gene

  2000cites this paper
• Increased CBF velocity during word fluency in Huntington's disease patients.

  2000cites this paper
• Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene.

  2000cites this paper
• Huntington’s Disease

  1999cites this paper
• Comparison of mouse bioassay and immunoprecipitation assay for botulinum toxin antibodies

  1999cites this paper
• Longitudinal analysis of phonemic clustering and switching during word-list generation in Huntington's disease.

  1999cites this paper
• Clinical deficits in Huntington disease correlate with reduced striatal uptake on iodine-123 epidepride single-photon emission tomography

  1999cites this paper
• Exkurs: Therapie der Chorea Huntington

  1999cites this paper